Literature DB >> 24820418

TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage.

Abhinav K Jain, Kendra Allton, Aundrietta D Duncan, Michelle C Barton.   

Abstract

Tumor suppressor p53 protects cells from genomic insults and is a target of mutation in more than 50% of human cancers. Stress-mediated modification and increased stability of p53 promote p53 interaction with chromatin, which results in transcription of target genes that are critical for the maintenance of genomic integrity. We recently discovered that TRIM24, an E3-ubiquitin ligase, ubiquitinates and promotes proteasome-mediated degradation of p53. Here, we show that TRIM24 is destabilized by ATM-mediated phosphorylation of TRIM24S768 in response to DNA damage, which disrupts TRIM24-p53 interactions and promotes the degradation of TRIM24. Transcription of TRIM24 is directly induced by damage-activated p53, which binds p53 response elements and activates expression of TRIM24. Newly synthesized TRIM24 interacts with phosphorylated p53 to target it for degradation and termination of the DNA damage response. These studies indicate that TRIM24, like MDM2, controls p53 levels in an autoregulatory feedback loop. However, unlike MDM2, TRIM24 also targets activated p53 to terminate p53-regulated response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820418      PMCID: PMC4097665          DOI: 10.1128/MCB.01705-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

Authors:  Roger P Leng; Yunping Lin; Weili Ma; Hong Wu; Benedicte Lemmers; Stephen Chung; John M Parant; Guillermina Lozano; Razqallah Hakem; Samuel Benchimol
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

Review 3.  Making sense of ubiquitin ligases that regulate p53.

Authors:  Abhinav K Jain; Michelle Craig Barton
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

4.  Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage.

Authors:  R Khosravi; R Maya; T Gottlieb; M Oren; Y Shiloh; D Shkedy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

Authors:  R Maya; M Balass; S T Kim; D Shkedy; J F Leal; O Shifman; M Moas; T Buschmann; Z Ronai; Y Shiloh; M B Kastan; E Katzir; M Oren
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

6.  Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.

Authors:  N Dumaz; D W Meek
Journal:  EMBO J       Date:  1999-12-15       Impact factor: 11.598

Review 7.  ATM and related protein kinases: safeguarding genome integrity.

Authors:  Yosef Shiloh
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

8.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Nature       Date:  2003-01-30       Impact factor: 49.962

9.  The tripartite motif family identifies cell compartments.

Authors:  A Reymond; G Meroni; A Fantozzi; G Merla; S Cairo; L Luzi; D Riganelli; E Zanaria; S Messali; S Cainarca; A Guffanti; S Minucci; P G Pelicci; A Ballabio
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

Review 10.  TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases.

Authors:  Germana Meroni; Graciana Diez-Roux
Journal:  Bioessays       Date:  2005-11       Impact factor: 4.345

View more
  37 in total

1.  Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer.

Authors:  Li Ma; Lili Yuan; Jing An; Michelle C Barton; Qingyuan Zhang; Zhaoliang Liu
Journal:  Tumour Biol       Date:  2016-09-16

Review 2.  Negative auto-regulators trap p53 in their web.

Authors:  Xiang Zhou; Bo Cao; Hua Lu
Journal:  J Mol Cell Biol       Date:  2017-02-01       Impact factor: 6.216

3.  Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.

Authors:  Che-Pei Kung; Sakina Khaku; Matthew Jennis; Yan Zhou; Maureen E Murphy
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

Review 4.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

Review 5.  TRIMming p53's anticancer activity.

Authors:  S Elabd; G Meroni; C Blattner
Journal:  Oncogene       Date:  2016-02-22       Impact factor: 9.867

6.  Genetic regulation of the RUNX transcription factor family has antitumor effects.

Authors:  Ken Morita; Kensho Suzuki; Shintaro Maeda; Akihiko Matsuo; Yoshihide Mitsuda; Chieko Tokushige; Gengo Kashiwazaki; Junichi Taniguchi; Rina Maeda; Mina Noura; Masahiro Hirata; Tatsuki Kataoka; Ayaka Yano; Yoshimi Yamada; Hiroki Kiyose; Mayu Tokumasu; Hidemasa Matsuo; Sunao Tanaka; Yasushi Okuno; Manabu Muto; Kazuhito Naka; Kosei Ito; Toshio Kitamura; Yasufumi Kaneda; Paul P Liu; Toshikazu Bando; Souichi Adachi; Hiroshi Sugiyama; Yasuhiko Kamikubo
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

7.  Overexpression of TRIM24 is correlated with the progression of human cervical cancer.

Authors:  Li Lin; Weihua Zhao; Bo Sun; Xinyu Wang; Qiao Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

8.  Abrogation of FBW7α-dependent p53 degradation enhances p53's function as a tumor suppressor.

Authors:  Vivek Tripathi; Ekjot Kaur; Suhas Sampat Kharat; Mansoor Hussain; Arun Prasath Damodaran; Swati Kulshrestha; Sagar Sengupta
Journal:  J Biol Chem       Date:  2019-07-25       Impact factor: 5.157

9.  TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.

Authors:  Anna C Groner; Laura Cato; Jonas de Tribolet-Hardy; Tiziano Bernasocchi; Hana Janouskova; Diana Melchers; René Houtman; Andrew C B Cato; Patrick Tschopp; Lei Gu; Andrea Corsinotti; Qing Zhong; Christian Fankhauser; Christine Fritz; Cédric Poyet; Ulrich Wagner; Tiannan Guo; Ruedi Aebersold; Levi A Garraway; Peter J Wild; Jean-Philippe Theurillat; Myles Brown
Journal:  Cancer Cell       Date:  2016-05-26       Impact factor: 31.743

10.  Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest.

Authors:  Sae Jeong Park; Hyun Kyung Kong; Ye Sol Kim; Yeon Seon Lee; Jong Hoon Park
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.